Azenta CEO John Marotta granted 122,269 RSUs of common stock

Rhea-AI Filing Summary

Azenta, Inc. (AZTA) reported an equity award to its President and CEO, John Marotta. On 11/24/2025 he received a grant of 122,269 restricted stock units (RSUs) of Azenta common stock at a price of $0.00 per unit, recorded as an acquisition of non-derivative securities. Following this grant, he beneficially owns 217,268.78 shares of common stock.

The RSU award was sized by dividing a target award value by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date. These RSUs are subject to time-based vesting, with 33-1/3% of the units scheduled to vest each year, beginning on November 24, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marotta John

(Last) (First) (Middle)

C/O AZENTA, INC.

200 SUMMIT DRIVE, 6TH FLOOR

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Azenta, Inc. [ AZTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common	11/24/2025		A		122,269(1)	A	$0.00	217,268.78	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026.

	/s/Ephraim Starr, Attorney-in-fact for John Marotta	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Azenta (AZTA) disclose in this Form 4 filing?

Azenta (AZTA) disclosed that its President and CEO, John Marotta, received a grant of 122,269 restricted stock units (RSUs) of Azenta common stock on 11/24/2025.

How many Azenta (AZTA) RSUs were granted to CEO John Marotta?

John Marotta was granted 122,269 RSUs of Azenta common stock, recorded at a grant price of $0.00 per unit as equity compensation.

What is the vesting schedule for John Marotta’s Azenta (AZTA) RSU grant?

The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026, until fully vested over three years.

How was the number of Azenta (AZTA) RSUs in this grant determined?

The 122,269 RSUs were calculated by dividing a target award value by the average closing price of Azenta’s common stock over the 20 trading days ending on the grant date.

How many Azenta (AZTA) shares does John Marotta beneficially own after this grant?

After the reported RSU grant, John Marotta beneficially owns 217,268.78 shares of Azenta common stock as shown in the filing.

What is John Marotta’s role and relationship to Azenta (AZTA)?

John Marotta is identified as both a Director and an Officer of Azenta, serving as the company’s President and CEO.